The CBCT step was eliminated which streamlined the clinical protocol as CBCT verification is limited to couch zero. The treatment time was reduced by 5-7 minutes per fraction and the dose at the verification step reduced from c.72mGy to c. 0.335mGy (AAPM TG 75). Patient intrafraction data was benchmarked against the 1mm accuracy delivered by the conventional frame based radiosurgery. The results demonstrate that this criteria was met, with all translational errors well below 1mm and rotational errors below 0.5degrees which we use as the online tolerance for treatment delivery (Table 1) .
Conclusions:
As per previous studies a modest difference between ET x-ray and CBCT corrections was found in patient data but not in phantom testing, even though in this study both sets of images were analyzed with six degrees of freedom in the Brainlab software. The difference is due to inherent differences in the modalities, as it cannot be fully accounted for by intrafraction motion. The imaging strategy was optimized and streamlined, informed by the quantified stability of the masking system and the optimum positioning verification modality for cranial SRS procedures. Purpose/Objective: Radical radiotherapy with hypofractionated (HF) regimen is used in some busy centres for the treatment of early glottic cancers (EGC). We at our centre conducted an audit of the EGC treated with HF regimen and analysed the factors impacting local control. Materials and Methods: 59 unselected patients of histologically confirmed glottis squamous cell cancer patients treated during September 2011 to July 2014, were analysed. Only patients with stage T1/ T2 N0 as per the 7th edition of AJCC and who were treated using a HF regimen of 5500cGy delivered in 20 were included. Only patients with a minimum follow up of six months, n=56, were analysed. The outcomes and treatment as well as tumour related factors associated were systematically analysed and correlated to outcome. We also did an audit of the online matching of the carotid sparing (CS) cohort to analyse the importance of residual errors and its impact on local control. Results: This analysis was done at a median follow up of 18 months. 89.3% of the patients were T1 and 10.7% were T2. 57.1% patients were treated using IMRT (93.8% helical tomotherapy (HT) and 6.2% VMAT), the remaining were treated using 3DCRT. 18 patients in the IMRT group had undergone carotid sparing (CS) as part of a prospective study. A bolus was required for dose build up in the anterior commissure (AC) region in 72.7% patients with a risk of involvement to that area. All patients achieved a complete response at the first post radiation visit 4-6 weeks post therapy. 7 patients had grade 2 or more dermatitis.15 patients (26.8%) developed grade 2 or more dysphagia. Overall 10.7% patients had failure of treatment with 5 patients having a local recurrence and 1 patient failing regionally in the nodal region. One patient died of an unrelated medical condition. Clinical stage did not have any significant bearing on the control rates (T1a vs T1b vs T2 8.6% vs 13.3% vs 16.7%; p=0.8). All failures occurred in the IMRT group with 10.7% failures overall and 18.7% within the group. All failures occurred in the HT IMRT arm (5/6 had disease involving AC, anterior cord (1/6)). CS was significantly associated with failure with 5/6 recurrence occurring in this group (p=0.005). The PTV indices D99 (p=0.01), D50 (p=0.001) and HI (p=0.004) were significantly better in those who failed. Other treatment related factors like the AC involvement, prolongation of the duration of radiation course did not have significant relation with the outcome. Also the online matching of the patients who had undergone CS was done to analyse the impact of errors in matching. Residual errors were calculated for these patients based on the offline matching shift data. None of the residual translational errors turned out to be significantly related to recurrence in the 18 patients in the carotid spared group. Conclusions: Hypofractionated radiotherapy is safe with acceptable toxicity rates and good overall control. However in tumors with anterior extension there may be higher chance of failure. Good image guidance protocols with proper placement and matching of bolus is very important.
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